重症成人客观镇静监测实践评估:系统评价与Meta分析
该系统评价与Meta分析纳入20项研究(3410例患者),其中15项评估处理脑电图监测,2项评估脑电图监测,3项评估处理面部肌电监测。处理脑电图监测与机械通气时长缩短无关(SMD -0.33;95%CI -0.91至0.25;I²=84.4%),但显示住院时间缩短(SMD -0.89;95%CI -1.17至-0.62;I²=13.4%)、总镇静剂剂量减少(丙泊酚当量,mg)(SMD -1.29;95%CI -2.27至-0.31;I²=96.6%)和总阿片类药物剂量减少(吗啡当量,mg)(SMD -0.40;95%CI -0.76至-0.04;I²=77.0%)。处理面部肌电监测与不良事件风险增加相关(风险比1.40;95%CI 1.03-1.90;I²=0.00%)。65%(n=13/20)的纳入研究存在严重偏倚风险。
要点
- 处理脑电图监测与机械通气时长缩短无关(SMD -0.33;95%CI -0.91至0.25;I²=84.4%)。
- 处理脑电图监测与住院时间缩短相关(SMD -0.89;95%CI -1.17至-0.62;I²=13.4%)。
- 处理脑电图监测与总镇静剂剂量减少相关(丙泊酚当量,mg)(SMD -1.29;95%CI -2.27至-0.31;I²=96.6%)。
- 处理脑电图监测与总阿片类药物剂量减少相关(吗啡当量,mg)(SMD -0.40;95%CI -0.76至-0.04;I²=77.0%)。
- 处理面部肌电监测与不良事件风险增加相关(风险比1.40;95%CI 1.03-1.90;I²=0.00%)。
适用人群与场景
- 接受有创机械通气的成人重症患者。
- 纳入观察性或干预性原始研究,评估任何客观镇静监测实践(如脑电图[EEG]),并报告机械通气时长或其他次要结局(如住院时间)。
研究设计与关键结果
- 系统评价与Meta分析纳入20项研究(3410例患者),其中15项评估处理脑电图监测,2项评估脑电图监测,3项评估处理面部肌电监测。
- 处理脑电图监测与机械通气时长缩短无关(SMD -0.33;95%CI -0.91至0.25;I²=84.4%)。
- 处理脑电图监测与住院时间缩短相关(SMD -0.89;95%CI -1.17至-0.62;I²=13.4%)。
- 处理脑电图监测与总镇静剂剂量减少相关(丙泊酚当量,mg)(SMD -1.29;95%CI -2.27至-0.31;I²=96.6%)。
- 处理脑电图监测与总阿片类药物剂量减少相关(吗啡当量,mg)(SMD -0.40;95%CI -0.76至-0.04;I²=77.0%)。
- 处理面部肌电监测与不良事件风险增加相关(风险比1.40;95%CI 1.03-1.90;I²=0.00%)。
- 65%(n=13/20)的纳入研究存在严重偏倚风险。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入观察性或干预性原始研究。
- 65%(n=13/20)的纳入研究存在严重偏倚风险。
对床旁实践的改变
- 处理脑电图监测与机械通气时长缩短无关,但可能减少镇静剂和阿片类药物暴露并缩短住院时间。
- 处理面部肌电监测可能增加不良事件风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To conduct a systematic review and meta-analysis to determine if objective sedation monitoring practices reduce duration of mechanical ventilation and other clinical and healthcare utilization outcomes in critically ill adult patients.
DATA SOURCES: Ovid MEDLINE, Embase, CINAHL, PsycINFO, Web of Science, Cochrane Library and PROSPERO, and the grey literature.
STUDY SELECTION: Observational or interventional original research studies, conducted in adult critically ill patients undergoing invasive mechanical ventilation, evaluating any objective sedation monitoring practice (e.g., electroencephalography [EEG]), and reporting on duration of mechanical ventilation or other secondary outcomes (e.g., length of stay) were included.
DATA EXTRACTION: Meta-analysis was performed for pooled estimates of the primary outcome and each individual secondary outcome using random-effects modeling.
DATA SYNTHESIS: Twenty studies (3410 patients) were included with 15 studies evaluating processed EEG monitoring, 2 evaluating EEG monitoring, and 3 evaluating processed facial electromyography (EMG). Processed EEG was not associated with reduced duration of mechanical ventilation (standardized mean difference [SMD] -0.33; 95% CI, -0.91 to 0.25; I2 = 84.4%). Secondary outcomes of processed EEG monitoring showed decreased hospital length of stay (days) (SMD -0.89; 95% CI, -1.17 to -0.62; I2 = 13.4%), reduced total sedative dose (reported in propofol equivalents, mg) (SMD -1.29; 95% CI, -2.27 to -0.31; I2 = 96.6%), and reduced total opioid dose (reported in morphine equivalents, mg) (SMD -0.40; 95% CI, -0.76 to -0.04; I2 = 77.0%). Processed facial EMG was associated with an increased risk of adverse events (risk ratio 1.40; 95% CI, 1.03-1.90; I2 = 0.00%). Risk of bias was serious for 65% (n = 13/20) of included studies.
CONCLUSIONS: Processed EEG monitoring is not associated with reduced duration of mechanical ventilation but may be associated with reduced sedative and opioid exposure and decreased hospital length of stay. Processed facial EMG monitoring may be associated with increased adverse events.
参考来源
- Jaworska N, Hezam A, Poulin T, et al. Evaluation of Objective Sedation Monitoring Practices in Critically Ill Adult Patients: A Systematic Review and Meta-Analysis. Crit Care Explor. 2025. PMID: 40788313. doi:10.1097/CCE.0000000000001297
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。